SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithKline Consumer Healthcare informs about closure of trading window

07 Jun 2017 Evaluate

In accordance with the Company’s Policy on Insider Trading, GlaxoSmithKline Consumer Healthcare has informed about the date of commencement of closing of Trading Window shall be from June 15, 2017 and shall end 48 hours after public announcement of the Audited / Un-Audited Financial Results for the First Quarter of Financial Year 2017-18.

The above information is a part of company’s filings submitted to BSE.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle 1375.85
Varun Beverages 522.10
Britannia Inds 5165.35
LT Foods 380.90
Hatsun Agro Product 917.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: